SCHEMBL30096051

SCHEMBL30096051

CC(C)CC(C)n1nc(-c2cnco2)c2c(N)nc(N)nc21

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MTOR P42345 5/20 0.54
RICTOR Q6R327 3/20 0.54
RPTOR Q8N122 3/20 0.54
MAPKAP1 Q9BPZ7 3/20 0.54
MLST8 Q9BVC4 3/20 0.54
PIK3CA P42336 3/20 0.39
PIK3CD O00329 2/20 0.34
ABL1 P00519 2/20 0.34
EGFR P00533 2/20 0.34
HCK P08631 2/20 0.34
SRC P12931 2/20 0.34
KDR P35968 2/20 0.34
PIK3CG P48736 2/20 0.34
EPHB4 P54760 2/20 0.34
PRKDC P78527 2/20 0.34
PI4KB Q9UBF8 2/20 0.34
PIK3CB P42338 1/20 0.34
AAK1 Q2M2I8 15/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22494331 0.72 MTOR (0.50) MTORRICTORRPTORMAPKAP1MLST8
SCHEMBL30381902 0.72 MTOR (0.50) MTORRICTORRPTORMAPKAP1MLST8
SCHEMBL22494329 0.72 MTOR (0.50) MTORRICTORRPTORMAPKAP1MLST8
SCHEMBL22494262 0.70 MTOR (1.00) MTORRICTORRPTORMAPKAP1MLST8
SCHEMBL22494261 0.70 MTOR (1.00) MTORRICTORRPTORMAPKAP1MLST8
SCHEMBL30214463 0.70 SRC (0.68) MTORPIK3CAPIK3CDABL1EGFR
SCHEMBL22494333 0.70 MTOR (1.00) MTORRICTORRPTORMAPKAP1MLST8
SCHEMBL22494330 0.70 MTOR (1.00) MTORRICTORRPTORMAPKAP1MLST8
SCHEMBL22494342 0.69 MTOR (0.70) MTORRICTORRPTORMAPKAP1MLST8
SCHEMBL22494344 0.69 MTOR (0.70) MTORRICTORRPTORMAPKAP1MLST8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4370517-A1 SYNTHESIS OF CHIRAL SUBSTITUTED PYRAZOLOPYRIMIDINE COMPOUNDS Galderma Holding SA (CH) 2024-05-22 EP disclosed
WO-2023285926-A1 SYNTHESIS OF CHIRAL SUBSTITUTED PYRAZOLOPYRIMIDINE COMPOUNDS Galderma Holding SA (CH) 2023-01-19 WO disclosed